Real-time enrollment status for this flexible hammertoe clinical trial
Current Status
Recruiting
Checked: October 30, 2026 at 1:51 AM UTC
| NCT Number | NCT07759362 |
| Recruiting Status | Recruiting |
| Condition | Flexible Hammertoe |
| Phase | PHASE3 |
| Target Enrollment | 554 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Endo USA Inc., a Keenova Therapeutics Company |
| Last Updated on CT.gov | September 14, 2026 (Sep 14, 2026) |
As of October 30, 2026: Clinical trial NCT07759362 is currently recruiting participants. This phase3 study for flexible hammertoe is actively seeking new participants at 7 locations across the United States. The study is sponsored by Endo USA Inc., a Keenova Therapeutics Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07759362 is actively recruiting participants as of October 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07759362 was last updated Sep 14, 2026 (September 14, 2026). HelloStudys verifies this status automatically.